ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]

RxCUI: 1799178
RxNorm name: ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]
Display name: VITRON-C REFORMULATED JUL 2016 (Oral Pill)
Full name: ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]
Term type: SBD
Status: Active
Strength: 125-65 mg
Dose form: DR Tab
Route: Oral Pill
Updated: 2026-10-24 12:46:00

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 082016
Active start: 082016
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
ascorbic acid	125 MG / 1 EACH	ascorbic acid	ascorbic acid
iron carbonyl	65 MG / 1 EACH	iron carbonyl	ferrous cation

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Delayed Release Oral Tablet	10312

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
ascorbic acid	1151
iron carbonyl	262150

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Vitron-C Reformulated Jul 2016 (vitamin C 125 MG / elemental iron 65 MG) Oral Tablet	1	NAMES
RxNorm Name	ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]	1	NAMES
RxNorm Synonym	3 linked values vit-C 125 MG / Iron Carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016] vitamin C 125 MG / Iron Carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016] Vitron-C Reformulated Jul 2016 (vitamin C 125 MG / elemental iron 65 MG) Oral Tablet	3	NAMES
TTY	SBD	1	ATTRIBUTES
RxCUI	1799178	1	CODES
MMSL_CODE	BD28503	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
63736000046	rxnav_ndcs	yes
63736012301	rxnav_ndcs	yes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	A11GA	Ascorbic acid (vitamin C), plain	ATC1-4		ascorbic acid
ATC	G01AD	Organic acids	ATC1-4		ascorbic acid
ATC	S01XA	Other ophthalmologicals	ATC1-4		ascorbic acid
FDASPL	D001205	Ascorbic Acid	CHEM	has_chemical_structure	ascorbic acid
FDASPL	N0000193618	Vitamin C	EPC	has_epc	ascorbic acid
MEDRT	D001205	Ascorbic Acid	CHEM	has_ingredient	ascorbic acid
MEDRT	D058085	Iron Compounds	CHEM	has_ingredient	iron carbonyl
MEDRT	D000743	Anemia, Hemolytic	DISEASE	ci_with	iron carbonyl
MEDRT	D018798	Anemia, Iron-Deficiency	DISEASE	may_treat	iron carbonyl
MEDRT	D018798	Anemia, Iron-Deficiency	DISEASE	may_prevent	iron carbonyl
MEDRT	D000749	Anemia, Megaloblastic	DISEASE	ci_with	iron carbonyl
MEDRT	D003139	Common Cold	DISEASE	may_treat	ascorbic acid
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	ascorbic acid
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	iron carbonyl
MEDRT	D006432	Hemochromatosis	DISEASE	ci_with	iron carbonyl
MEDRT	D006486	Hemosiderosis	DISEASE	ci_with	iron carbonyl
MEDRT	D006959	Hyperoxaluria	DISEASE	induces	ascorbic acid
MEDRT	D008708	Methemoglobinemia	DISEASE	may_treat	ascorbic acid
MEDRT	D011250	Pregnancy Complications, Hematologic	DISEASE	may_treat	iron carbonyl
MEDRT	D012148	Restless Legs Syndrome	DISEASE	may_treat	iron carbonyl
MEDRT	D012614	Scurvy	DISEASE	may_treat	ascorbic acid
MEDRT	D020176	Tyrosinemias	DISEASE	may_treat	ascorbic acid
MEDRT	D014950	Wounds, Penetrating	DISEASE	may_treat	ascorbic acid
MEDRT	N0000000220	Electrolyte Activity	MOA	has_moa	iron carbonyl
MEDRT	N0000000163	Enzyme Interactions	MOA	has_moa	ascorbic acid
MEDRT	N0000000170	Free Radical Scavenging Activity	MOA	has_moa	ascorbic acid
MEDRT	N0000008337	Cellular Activity Alteration	PE	has_pe	ascorbic acid
MEDRT	N0000009319	Increased Erythroid Cell Production	PE	has_pe	iron carbonyl

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Vitron-C Reformulated Jul 2016	rxnav_allrelated
DF	DF	Delayed Release Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	ascorbic acid	rxnav_allrelated
IN	IN	iron carbonyl	rxnav_allrelated
MIN	MIN	ascorbic acid / iron carbonyl	rxnav_allrelated
SBD	SBD	ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]	rxnav_allrelated
SBDC	SBDC	ascorbic acid 125 MG / iron carbonyl 65 MG [Vitron-C Reformulated Jul 2016]	rxnav_allrelated
SBDF	SBDF	ascorbic acid / iron carbonyl Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]	rxnav_allrelated
SBDG	SBDG	Vitron-C Reformulated Jul 2016 Oral Product	rxnav_allrelated
SBDG	SBDG	Vitron-C Reformulated Jul 2016 Pill	rxnav_allrelated
SCD	SCD	ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet	rxnav_allrelated
SCDC	SCDC	ascorbic acid 125 MG	rxnav_allrelated
SCDC	SCDC	iron carbonyl 65 MG	rxnav_allrelated
SCDF	SCDF	ascorbic acid / iron carbonyl Delayed Release Oral Tablet	rxnav_allrelated
SCDG	SCDG	ascorbic acid / iron carbonyl Oral Product	rxnav_allrelated
SCDG	SCDG	ascorbic acid / iron carbonyl Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	125 MG / 65 MG
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
NAMES	Prescribable Synonym	Vitron-C (iron) 65 MG / 125 MG Oral Tablet, Reformulated Jul 2016
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon